Home › Compare › DOCRF vs ABBV
DOCRF yields 9756.10% · ABBV yields 3.06%● Live data
📍 DOCRF pulled ahead of the other in Year 1
Combined, DOCRF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DOCRF + ABBV for your $10,000?
CloudMD Software & Services Inc. operates as a healthcare technology company in North America. The company operates through three segments: Clinic Services & Pharmacies, Digital Health Services, and Enterprise Health Solutions. It offers enterprise health solutions, including mental health support, healthcare navigation, rehabilitation and assessments, education, and absence management and occupational health. The company also provides billing and electronic medical records solutions; MyHealthAccess, a patient portal that enables online appointment booking and virtual care visits; and Health and Wellness, a real time intervention and prevention platform, which enables an automated real time inquiry of disparate data sources in various domains, identify indicators, and compute risk scores. In addition, it offers iMD platform for peer-reviewed educational resources; telemedicine services; and VisionPros, an online vision care platform that provides contact lenses to customers. Further, the company operates a network of hybrid medical and rehabilitation clinics; and medical clinics for family practice and patient care on-site, as well as retails prescription drugs, over-the-counter drugs, and other front store items through two pharmacies. Additionally, it provides patient support programs that offers navigation and support for holistic disease management and clinical treatment outcomes; and pharmaceutical logistic services, including drug distribution and patient navigation assistance, as well as real-time universal disease management software. The company was formerly known as Premier Health Group Inc. and changed its name to CloudMD Software & Services Inc. in February 2020. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.
Full DOCRF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.